Comparative study of anti-CCP and RF for the diagnosis of rheumatoid arthritis

APLAR Journal of Rheumatology

Volumn 10, Issue 2, 2007, Pages 121-124

  Sharif, Sakineh Khatoun ^a,b   Eghbal, Shahin ^a   Gharibdoost, Farhad ^a   Kbarian, Mahmood A ^a   Shahram, Farhad ^a   Nadji, Abdolhadi ^a   Jamshidi, Ahmad Reza ^a   Davatchi, Fereydoun ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti CCP; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

EID: 34249661581     PISSN: 02190494     EISSN: 14798077     Source Type: Journal    
DOI: 10.1111/j.1479-8077.2007.00272.x     Document Type: Article

References (13)

1. O'Dell JR (2005) Rheumatoid arthritis: The clinical picture. In: Koopman WJ, Moreland LW, eds. Arthritis and Allied Conditions. A Textbook of Rheumatology pp. 1165-94. Lippincott Williams & Wilkins, Baltimore, MA.
2. Rose HM, Ragan C, Pearce E, Lipman MO (1949) Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Medical 68, 1-6.
3. Bizzaro N, Mazzanti G, Tonutti E, et al. (2001) Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47, 1089-93.
4. Schellekens GA, Visser H, de jong BA, et al. (2000) The diagnostic properties of RA antibodies to cyclic citrullinated peptide. Arthritis Rheum 43, 155-63.
5. Schellekens GA, de jong BA, van den Hoogen FH, et al. (1998) Citrullin is an essential constituent of antigenic determinants recognized by RA, specific autoantibodies. J Clin Invest 101, 273-8.
6. Lee DM, Schur PH (2003) Clinical utility of Anti-CCP, assay in Patient with rheumatic disease. Ann Rheum Dis 62, 870-4.
7. Arnett FC, Edworthy SM, Bloch DA, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315-24.
8. Metz CE (1978) Basic principles of ROC analysis. Semin Nucl Med 8, 283-98.
9. Fleming A, Benn RT, Corbett M, Wood PH (1976) Early rheumatoid disease. Patterns of joint involvement. Amm Rheum Dis 35, 361-4.
10. Schumacher HR (1982) Palindromic onset of rheumatoid arthritis. Arthritis Rheum 25, 361-5.
11. Van Gaalen FA, linn-Rasker SP, Van Venrooij WJ, et al. (2004) Autoantibodies to cyclic citrullinated peptides predict progression to RA, in patients with undifferentiated Arthritis. Arthritis Rheum 50, 709-15.
12. Bridges SL (2001) Rheumatoid factor. In: Koopman WJ, ed. Arthritis and Allied Conditions, pp. 1223-44. Lippincott, Williams & wilkins, Philadelphia.
13. Davatchi F, Akbarian M, Shahram F, et al. (in press) DMARD combination therapy. Rheumatoid Arthritis.